Covid-19 FluoGene® Q

Covid-19 FluoGene® Q

SARS-CoV-2 is a novel coronavirus causing the coronavirus disease 2019 (Covid-19). It is closely related to the SARS virus and was first identified in December 2019 in Wuhan, China. By now it has spread globally resulting in an ongoing pandemic.

Covid-19 FluoGene® Q kit is a CE-IVD marked dual-target multiplex qRT-PCR for the qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific RNA. The system works with any RNA isolation method, but ideally it is combined with automated viral DNA/RNA extraction consisting of the BEXS12 instrument and the BEXS12 Ready Viral DNA/RNA Bead Kit.

The isolated RNA target is transcribed into cDNA and the target genes are amplified in a single step qRT-PCR. The primer probe mixes detect the SARS-CoV-2 specific genes M and N1, as well as the human RNase P gene as an internal control reaction. A positive control is included in the test system. The kit is validated on the FluoQube, QTower, ABI7500, and the QuantStudio 6 Pro.


Features:

  • One-Step qRT-PCR rapid test
  • Detection of SARS-CoV-2 genes: Mand N1
  • Detection of internal control human RNasePgene in each well
  • Positive control & Nuclease-free water provided
  • Validated in combination mit with BEXS 12 automatisated RNA Extraction   
  • Validated on FluoQube, QTower, ABI7500, and Quantstudio 6 Pro
  • CE IVD (outside of the U.S.A. and Canada)

Art. No. Name Description
003 COV 096 Covid-19 FluoGene Q 96 Tests/Kit
003 COV 960 Covid-19 FluoGene Q 960 Tests/Kit
003 COV PKo Positiv Control (Covid-19 FluoGene Q) 30 µL

Instruction for Use: Covid-19 FluoGene® Q

Contact Form

* obligatory

Call

+49 (0) 6173 607930

Call from USA/Canada

+1 (888) 352 2196